These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22373849)

  • 1. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapy allergens ordinance ("Therapieallergene-Verordnung"). Background and effects].
    Englert L; May S; Kaul S; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):351-7. PubMed ID: 22373848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety monitoring of cell-based medicinal products (CBMPs)].
    Funk MB; Frech M; Spranger R; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1239-46. PubMed ID: 26391098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory environment for allergen-specific immunotherapy.
    Kaul S; May S; Lüttkopf D; Vieths S
    Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for use in man: current regulatory situation in the Federal Republic of Germany.
    Haase M
    Dev Biol Stand; 1990; 71():213-20. PubMed ID: 2205526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written.
    Klimek L; Werfel T; Vogelberg C; Jung K
    Allergo J Int; 2015; 24(3):84-93. PubMed ID: 26120551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
    Englert L; Mahler V; Bonertz A
    Curr Allergy Asthma Rep; 2021 May; 21(5):32. PubMed ID: 33970347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Batch release of immunoglobulin and monoclonal antibody products].
    Gross S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1185-7. PubMed ID: 25200488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children.
    Eichler I; Soriano ES
    Allergy; 2011 Aug; 66(8):999-1004. PubMed ID: 21426358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification of cell-based medicinal products and legal implications: An overview and an update].
    Scherer J; Flory E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1201-6. PubMed ID: 26369760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy of allergies: current status].
    Mahler V; Kleine-Tebbe J; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European allergen extract units and potency: review of available information.
    Larenas-Linnemann D; Cox LS;
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.
    Bonertz A; Roberts GC; Hoefnagel M; Timon M; Slater JE; Rabin RL; Bridgewater J; Pini C; Pfaar O; Akdis C; Goldstein J; Poulsen LK; van Ree R; Rhyner C; Barber D; Palomares O; Sheikh A; Pawankar R; Hamerlijnk D; Klimek L; Agache I; Angier E; Casale T; Fernandez-Rivas M; Halken S; Jutel M; Lau S; Pajno G; Sturm G; Varga EM; Gerth van Wijk R; Bonini S; Muraro A; Vieths S
    Allergy; 2018 Jan; 73(1):64-76. PubMed ID: 28771830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Innovation Office of the Paul-Ehrlich-Institut. Regulatory support during the scientific development of ATMP].
    Ziegele B; Dahl L; Müller AT
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):857-66. PubMed ID: 21698540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality requirements for allergen extracts and allergoids for allergen immunotherapy.
    Zimmer J; Bonertz A; Vieths S
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():4-11. PubMed ID: 29128092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.